Fergon

Quick links to important sections

Fergon

Method of action: Antianemic

Treatment option: Pregnancy

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fergon

Quick Facts

Property Description
Active ingredient Ferrous Gluconate (INN)
Form Oral tablet or Capsule
Pharmacological class Antianemic agent (Hematinic), Mineral supplement
General purpose Iron replacement to support oxygen transport
Origin Synthetic/Derived Iron Salt

Defining Fergon: An Antianemic Mineral Preparation

Fergon is a recognized brand name for a medicine classified primarily as an antianemic agent and an essential mineral supplement. The medicine’s core constituent is Ferrous Gluconate, an oral iron preparation typically available as an oral tablet or capsule. As a hematinic, its fundamental role is established in clinical practice to address deficiencies of iron within the body. While specific regulatory status varies, the product is often positioned as an accessible option for individuals needing consistent daily iron support.

Composition and Unique Features of Ferrous Gluconate

The active constituent, Ferrous Gluconate, is a specific type of iron salt synthesized for reliable oral administration. The chemical structure involves ferrous iron (Fe^2+) bound to the gluconate moiety, a formulation that is used to provide a source of elemental iron with often improved gastrointestinal tolerance compared to older salt forms. Ferrous Gluconate is established for use in correcting low iron levels in the blood, serving as a reliable supplement. This particular formulation is designed to deliver bioavailable elemental iron to the body.

General Purpose of this Iron Supplement

The general purpose of taking this iron preparation is to support the body’s essential ability to maintain oxygen transport throughout its system. Iron is a crucial component necessary for the production of hemoglobin, the protein in red blood cells that carries oxygen. By providing readily available elemental iron, the supplement supports the formation of healthy blood components and is intended to help the body reverse physiological deficits associated with insufficient iron availability.

Regulatory References

  1. MedlinePlus Drug Information
  2. NIH Office of Dietary Supplements

What side effects are possible with Fergon?

Possible Side Effects and Safety Information

The officially documented safety profile for oral ferrous gluconate is primarily defined by effects on the Gastrointestinal System. Regulatory classifications note that common adverse reactions typically include nausea, vomiting, constipation, diarrhea, and stomach pain. These gastrointestinal disturbances are often described in regulatory contexts as temporary and may subside with continued use. An expected, non-serious effect is the darkening of stools, which can persist for the duration of therapy.

Classification Common Adverse Reactions
Gastrointestinal Nausea, Vomiting, Diarrhea, Constipation, Stomach Pain, Loss of Appetite
Other Darkening of Stools, Temporary Teeth Staining (liquid forms)

The safety profile includes specific warnings about serious adverse reactions. Accidental overdose of iron-containing products is cited in regulatory documents as a leading cause of fatal poisoning, particularly in children under six years of age, necessitating strict caution regarding storage. Rare but serious gastrointestinal events such as necrosis or perforation have also been documented.

Population-Specific Safety Considerations are defined in official labeling. The medicine is contraindicated for individuals with existing conditions of iron overload, such as hemochromatosis or hemosiderosis, or for those with anemias not caused by iron deficiency. High-level safety restrictions also note that oral iron may interfere with the absorption of certain concomitantly administered oral medications, such as tetracycline antibiotics.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Ferrous Gluconate is characterized by the corrosive and systemic toxicity resulting from the acute ingestion of excessive elemental iron. Official regulatory documents describe a sequence of manifestations beginning with severe gastrointestinal distress, including vomiting (which may be bloody), diarrhea, and profound abdominal pain. These early signs may be accompanied by systemic changes such as lethargy and tachycardia.

The toxicity can progress rapidly to severe life-threatening outcomes. Documented complications involve the circulatory system (leading to hypotension and circulatory collapse), metabolic disturbance (acidosis), and organ damage, including hepatic necrosis and renal failure.

Immediate emergency medical attention must be sought if an overdose of this iron supplement is suspected. This immediate action is mandated due to the rapid onset and potentially fatal progression of severe iron toxicity. Regulatory documents specifically note that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six years of age.

Official management procedures documented in prescribing information include symptomatic and supportive treatment, serial monitoring of serum iron levels to assess toxicity severity, and the administration of the specific chelating agent, deferoxamine, for cases involving severe systemic toxicity.

Therapeutic Uses of Fergon

What Fergon Treats: Main Uses and Benefits

Fergon (Ferrous Gluconate) is commonly used in managing Iron Deficiency Anemia (IDA) and associated iron-deficient states in the body. This iron supplement is relevant in contexts involving heightened systemic burden and reduced iron levels.

The medication is commonly used across conditions presenting with systemic discomfort and is applied in addressing acute or disruptive episodes where red blood cell production may be affected. It assists with managing symptom clusters related to physical discomfort, primarily chronic fatigue, generalized weakness, and diminished physical stamina. This supportive management contributes to easing the overall symptom load during symptomatic periods.

It is considered relevant for easing symptoms in situations involving increased physiological stress, such as during pregnancy, after significant blood loss, or in certain chronic loss conditions. This targeted use provides support that helps ease the overall symptom burden when the body’s iron requirements are increased. As a therapeutic benefit, it may assist with maintaining functional stability and supports general well-being during symptomatic phases.

“This supportive management contributes to improved day-to-day comfort during symptomatic periods.”

Quick Fact: Relief for Fatigue
Primary Domain: Support for conditions associated with systemic imbalance.
Symptom Type: Symptoms related to systemic imbalance and physical discomfort.
Target Benefit: Helps improve day-to-day comfort during symptomatic periods.

Regulatory References

  1. NIH StatPearls on Iron Supplementation

Eligibility and Restrictions for Use

Eligibility for Ferrous Gluconate (Fergon)

Official regulatory documents define specific populations who are permitted or restricted from using Ferrous Gluconate, the active ingredient in Fergon.

Eligibility Status Patient Population or Condition
Contraindicated Patients with hemochromatosis or hemosiderosis (iron overload disorders)
Contraindicated Patients with hemolytic anemia (unless co-existing iron deficiency is present)
Contraindicated Patients with known hypersensitivity to iron salts or any formulation component
Use Restricted Patients with peptic ulceration, ulcerative colitis, or regional enteritis
Use Restricted Patients receiving frequent blood transfusions
Use Restricted Premature infants until adequate vitamin E stores are ensured
Use Acceptable Adults with iron-deficient states
Use Acceptable Pregnant and breastfeeding women

Some national labeling indicates that the product is not approved for use by anyone younger than 18 years old without medical guidance. Caution is also advised for patients with a history of liver problems or alcohol dependence. The eligibility profile is strictly defined by these governmental contraindications and restrictions.

What should I know about interactions with other medicines?

The official regulatory profile for Fergon (Ferrous Gluconate) is structured primarily around pharmacokinetic interactions that result in the reduced systemic exposure of either the iron preparation or the co-administered drug. This widely documented mechanism is due to the formation of polyvalent cation-binding complexes in the gastrointestinal tract.

Exposure-Altering Interactions and Restrictions

Co-administration is officially documented to reduce the absorption and effectiveness of several medications. These include Quinolone and Tetracycline antibiotics, thyroid preparations such as Levothyroxine, bisphosphonates (like Alendronate), and dopaminergic agents including Carbidopa and Levodopa. The absorption of Ferrous Gluconate is also decreased by Antacids and gastric acid-reducing agents like Proton Pump Inhibitors (PPIs).

To mitigate this interference, official regulatory documents mandate specific timing separation requirements. For example, administration must be separated by at least two to four hours for agents such as Levothyroxine and Ciprofloxacin.

Interactions with Diet and Supplements

Absorption of the iron preparation is further reduced when taken concurrently with specific food components. Regulatory information cites interference from substances rich in Phytates (cereals and legumes), Tannins (tea and coffee), and high amounts of Calcium (dairy products and supplements). Certain mineral supplements, including Zinc, are also documented to interfere with iron absorption.

Interaction classification Constraint in regulatory documents
Exposure-Reducing Mandatory administration timing separation
Food/Supplement Binding Avoidance or strict timing separation

The core regulatory constraint is centered on preventing absorption interference, making mandatory administration timing separation the primary requirement for these documented combinations.

Mechanism of Action

The mechanism of Ferrous Gluconate is based on its direct role as a mineral substrate for essential biological pathways.

Intestinal Iron Transport and Mobilization

The drug provides the elemental ferrous ion ( Fe^2+), which is actively transported across the intestinal lining by the Divalent Metal Transporter 1 (DMT1) and released into the bloodstream via Ferroportin. This initial mechanistic domain influences the systemic availability of iron, acting as a substrate supply mechanism.

Heme Synthesis and Oxygen-Carrying Capacity

Once mobilized, the Fe^2+ ion is delivered to the bone marrow where it directly fuels the erythropoiesis pathway, serving as the required cofactor for forming heme and subsequently hemoglobin. The resulting physiological effect is an increase in the systemic oxygen-carrying capacity, which results in the delivery of oxygen required for aerobic metabolism.

Constraint by Homeostatic Regulation

The efficacy of iron delivery is physiologically constrained by the regulatory hormone hepcidin, which can limit the release of iron from the intestinal cells via Ferroportin degradation. This limitation on the mechanism ensures that the speed of the physiological response is slow, being rate-limited by the body's time required for new red blood cell synthesis.

Dosage and Administration Information

How to Use Fergon: Administration Guidelines

Fergon, an oral iron preparation (Ferrous Gluconate), is administered following specific usage guidelines. These guidelines describe the standardized approach to dosing, frequency, and duration.


Administration Scope

Element Instruction
Route of administration Oral administration only.
Dosing schedule (Adults) One tablet (324 mg Ferrous Gluconate / 38 mg elemental iron) three to four times daily.
Timing in relation to meals Optimal absorption occurs when taken on an empty stomach; however, it may be taken with food to enhance user tolerance.
Preparation requirements Tablets must be swallowed whole with a full glass of water or juice. Non-chewable formulations must not be crushed.
Age-group administration rules Dosing for children requires explicit Consultation with a physician for individualized calculations.
Missed-dose rules If a dose is missed, it is taken when remembered. If close to the next scheduled dose, the missed dose is skipped to prevent doubling.

Course Duration

Treatment is structured as an extended regimen aimed not only at correcting immediate low hemoglobin levels but also at fully replenishing the body's iron stores. This replenishment phase typically necessitates the continuation of the prescribed dose for several months after the initial normalization of blood parameters. The consistency of the three to four times daily frequency is central to achieving this goal.

Recent Clinical Evidence

Recent Clinical Evidence

I. Pharmacological Studies

Initial laboratory and animal model studies examined the potential of ferrous gluconate to be absorbed and contribute to iron levels. Research has explored the drug's role in relation to the formation of hemoglobin, which is essential for oxygen transport in the body.

II. Clinical Assessment in Iron Deficiency

Clinical trials were designed to assess outcomes related to correcting iron deficiency, including improvements in ferritin and transferrin saturation levels. These studies typically involved individuals diagnosed with iron deficiency or iron deficiency anemia.

  • Treatment Duration: Studies generally assessed the drug over periods of 8 to 12 weeks to monitor the rate of iron store replenishment and evaluate red blood cell parameters.
  • Patient Groups: Trials have been conducted across various patient groups, including non-pregnant adults, children, and those with specific malabsorption conditions, to evaluate its use in different settings.

III. Tolerability and Comparative Research

Tolerability outcomes and potential adverse effects of ferrous gluconate have been investigated across multiple trials. Ferrous gluconate is sometimes studied comparatively against other iron salts, such as ferrous sulfate, to evaluate the respective rates of adverse gastrointestinal events and bioavailability.

IV. Key Assessment Measures

Clinical trials have assessed various research measures, including:

  • Hemoglobin (Hb) Levels: Studies examined changes in hemoglobin from baseline as a primary indicator of anemia correction.
  • Ferritin Levels: Trials investigated changes in serum ferritin, which is a measure of the body's stored iron.
  • Gastrointestinal (GI) Tolerance: Research monitored and reported the incidence and severity of adverse events, particularly those affecting the digestive system.

Key Studies & References

  1. Ferrous Gluconate vs Ferrous Sulfate: Differences in Elemental Iron and Constipation - PubMed.ai
  2. Ferrous gluconate: Dosing, contraindications, side effects, and pill pictures - epocrates online
  3. What is the recommended dosing for ferrous gluconate (iron supplement) in treating iron deficiency anemia? - Dr.Oracle AI

Frequently Asked Questions (FAQ)

Common questions about Fergon (FAQ)


Q: What is the difference between Fergon and other iron pills?

A: Official information indicates that Fergon contains Ferrous Gluconate, a specific type of iron salt. This formulation is recognized for providing elemental iron and is often recognized for its established gastrointestinal tolerability profile compared to some older iron salt forms.


Q: Why is my doctor recommending Fergon specifically?

A: Regulatory sources define its use for correcting iron deficiency. The specific choice of this salt is often based on its established characteristics, including its profile for absorption and tolerability among the available iron preparations.


Q: How quickly can I expect to see effects from taking Fergon?

A: Regulatory documents describe the iron treatment as an extended regimen aimed at fully replenishing the body's iron stores. The physiological response is rate-limited by the time needed to create new red blood cells, and the goal of full iron store correction generally takes a period of several months.


Q: Why do some people feel dizzy or lightheaded when they start Fergon?

A: The official safety profile notes that dizziness can be a symptom associated with accidental iron overdose. This effect is part of regulatory warnings regarding central nervous system effects documented in the official product information.


Q: Can Fergon affect the results of certain medical tests?

A: The drug is intended to address iron deficiency. Regulatory guidance uses laboratory tests, such as Hemoglobin and Ferritin levels, to assess and monitor changes in these iron-related blood parameters during the course of treatment.


Q: Can people with a specific health condition (e.g., kidney issues) use Fergon?

A: Official regulatory documents define specific populations who must not use this medication, such as those with iron overload disorders. For pre-existing conditions not listed as contraindications, such as kidney conditions, the use of this medication is determined on an individual basis.


Q: Is it true that taking Vitamin C helps with Fergon absorption?

A: Yes, some authoritative information indicates that the absorption of iron may be supported when taken concurrently with substances rich in Vitamin C.


Q: Will Fergon interfere with my blood pressure medication?

A: Regulatory documents indicate that iron preparations can interfere with the absorption of certain orally administered medications. This widely documented interaction is why a time separation is often required for specific drug combinations to maintain effectiveness.


Q: What evidence supports the use of Fergon for fatigue?

A: Clinical studies and official guidance support the use of iron preparations to correct iron deficiency, which is associated with symptoms like fatigue. The drug’s mechanism is to increase the body's oxygen-carrying capacity, addressing the physiological deficit.


Q: What happens if you stop taking Fergon suddenly?

A: The prescribed iron regimen is designed to fully replenish the body’s iron stores, a process that requires consistency over several months. Official guidance emphasizes the importance of completing the intended duration to achieve full iron store correction.


Q: What should I do if I experience a severe side effect from Fergon?

A: Official safety warnings emphasize the serious risk of accidental iron overdose, especially for young children. In the event of severe symptoms or suspected overdose, it is advised that the individual seek emergency medical attention or contact a poison control center.


Q: Does Fergon cause any long-term health issues?

A: Official regulatory documents emphasize the importance of avoiding the use of iron preparations in individuals with pre-existing iron overload disorders (hemochromatosis). Iron accumulation from misuse may lead to long-term health issues.


Q: Is Fergon safe for children to use?

A: Official labeling notes that dosing for children requires explicit individualized calculations by a physician. The product is also noted in regulatory documents as not approved for use by individuals under 18 years old.


Q: Are there any specific laboratory tests required before starting Fergon?

A: Clinical practice guidelines often involve the assessment of iron-related blood parameters, such as Hemoglobin and Ferritin levels, to confirm a diagnosis of iron deficiency before initiating therapy.


Q: Is Fergon suitable for vegetarians or vegans?

A: The official label lists all inactive ingredients in the formulation, such as magnesium stearate. The specific origin of these components is not universally defined on the core regulatory label and may require a review of the manufacturer’s specifications.


Q: Is there a generic version of Fergon available?

A: The active ingredient in Fergon is Ferrous Gluconate. This substance is listed on official labels as a generic substance and is often available from multiple manufacturers as 'Ferrous Gluconate Tablets, USP'.


Q: Can I crush or split the Fergon tablet if I have trouble swallowing it?

A: Official administration instructions state that the tablets must be swallowed whole with a full glass of water. Non-chewable formulations are described in the label as not suitable for crushing or splitting.


Q: Does taking Fergon make you feel tired at first?

A: While general tiredness is not consistently listed as a common effect in official adverse reaction documents, some users may report related symptoms. The safety profile lists dizziness as a potential symptom of iron overdose.


Q: Why is it advised to store Fergon away from heat and moisture?

A: The instructions to protect the product from excessive heat and moisture are based on drug stability requirements. Following these storage guidelines helps ensure the chemical integrity of the active ingredient is maintained, preserving the intended effectiveness of the medicine.


Q: What is the official safety classification of Fergon?

A: The medicine is officially classified as an Antianemic agent and a Mineral supplement. The regulatory safety profile mandates a specific warning emphasizing that accidental overdose is a leading cause of fatal poisoning in children under six years old.


Q: Does Fergon contain gluten or lactose?

A: The official label lists all inactive ingredients in the formulation. To determine the presence of substances like gluten or lactose, the full list of these ingredients specific to the manufacturer and batch must be reviewed.


Q: Is it true that iron supplements like Fergon can mask other health issues?

A: The official product information specifies that the medicine is contraindicated for anemias not caused by iron deficiency. Providing iron in those cases may not correct the underlying health disorder.


Q: What is the primary benefit of using ferrous gluconate over ferrous sulfate?

A: Ferrous Gluconate is recognized in clinical literature for providing a highly bioavailable source of elemental iron. It is often noted for its established gastrointestinal tolerability profile compared to other iron salt forms.


Q: Is the absorption rate of Fergon better than other types of iron?

A: Ferrous Gluconate is widely acknowledged as a bioavailable source of elemental iron. Its use is often associated with its established tolerability profile compared to other iron salt formulations.


Q: Is the drowsiness some users report linked to Fergon itself?

A: The official safety profile lists drowsiness as a potential symptom associated with accidental iron overdose. This is noted as a serious adverse reaction, emphasizing the need for strict adherence to administration guidelines.


Q: Are there different strengths of Fergon available?

A: The common adult tablet strength is officially listed as containing 324 mg of Ferrous Gluconate, which provides 38 mg of elemental iron. Specific alternative strengths would depend on individual manufacturer labeling and formulation.

How should Fergon be stored and disposed of?

Storage and Disposal Requirements

The storage and disposal of Fergon (Ferrous Gluconate) are governed by official regulatory guidelines to ensure product integrity and public safety.

Storage Conditions

Fergon must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). The product must be protected from excessive heat, moisture, and light. Containers should be kept tightly closed and should not be stored in environments like the bathroom, which often have high humidity.

Safety and Disposal

Official labeling mandates that this product must be kept out of the reach of children, as accidental overdose of iron-containing products is a leading cause of fatal poisoning in children. The container must feature a child-resistant closure. For disposal, unused or expired medication should not be flushed down the toilet. Consumers are directed to use a medicine take-back program or, if unavailable, to mix the product with an undesirable substance (such as dirt) in a sealed bag before placing it in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fergon found in:

A-Z Index: